Skip to main content
. 2014 Sep 6;4(5):572–590.

Table 5.

Changes in the expression levels of miRNA target genes in GSCs treated with 450 μM TMZ in the presence or absence of 1 mg/ml and 2 mg/ml OLE

TP53 OCT-4 SOX2 BCL2 c-myc c-met
Untreated
    2^(-Avg.(Delta(Ct)) 0.014418 0.02039 0.184795 0.042926 0.014458 0.011454
2 mg/ml OLE
    2^(-Avg.(Delta(Ct)) 0.002418 0.002828 0.013831 0.010352 0.002418 0.002418
    Fold Change 0.1677 0.1387 0.0748 0.2411 0.1672 0.2111
    95% CI (0.00001, 0.58) (0.00001, 0.46) (0.00001, 0.29) (0.00001, 0.98) (0.00001, 1.01) (0.00001, 1.09)
    * P value 0.314169 0.227929 0.175984 0.351612 0.341963 0.302438
2 mg/ml OLE + 450 µM TMZ
    2^(-Avg.(Delta(Ct)) 0.004743 0.002418 0.011502 0.007557 0.000975 0.000975
    Fold Change 0.329 0.1186 0.0622 0.176 0.0675 0.0851
    95% CI (0.00001, 1.10) (0.00001, 0.42) (0.00001, 0.26) (0.00001, 0.70) (0.00001, 0.39) (0.00001, 0.41)
    * P value 0.329112 0.220026 0.187845 0.353684 0.341256 0.29579
450 µM TMZ
    2^(-Avg.(Delta(Ct)) 0.121751 0.121751 0.133046 0.155609 0.121751 0.121751
    Fold Change 8.4444 5.9711 0.72 3.625 8.421 10.6295
    95% CI (0.00001, 28.07) (0.00001, 20.13) (0.00001, 2.91) (0.00001, 14.44) (0.00001, 50.50) (0.00001, 53.82)
    *P value 0.209763 0.224161 0.23702 0.484775 0.371175 0.681602
*

Evaluated with an independent sample T-test using RT2 Profiler PCR Array Data Analysis.